Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36 N.5, and our video podcast, CANCER BUZZ TV.
 

Share

    


In This Section

Home / About / Awards & Recognition / Clinical Research Award

Clinical Research Award

The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community.

 

2020 Clinical Research Award Recipient

Dr.Herbst-200x200 Roy S. Herbst, MD, PhD is affiliated with the Yale Comprehensive Cancer Center and Yale School of Medicine in New Haven, Connecticut. He serves as Ensign Professor of Medicine; Professor of Pharmacology; Chief of Medical Oncology; and Associate Director for Translational Research. Dr. Herbst has worked over several decades as a pioneer of personalized medicine and immunotherapy to identify biomarkers and bring novel targeted treatments and immunotherapies to patients, serving as principal investigator for numerous clinical trials testing these agents in advanced stage lung cancers. His work led to the approval of several therapies that have revolutionized the field and greatly improved patient survival.  His work on "umbrella” trials spurred FDA approvals of targeted therapies and new cancer drugs. Nationally, he works closely with public-private partnerships to develop large master protocol clinical studies, such as Lung-MAP.

Dr. Herbst testified on the importance of medical research before the House of Representatives 21st Century Cures committee and served as a prominent figure in this arena for nine years as a member of the National Academy of Medicine’s Cancer Policy Forum, where he organized several meetings focused on policy issues in personalized medicine and tobacco control.

2020 Award Presentation

begin-quoteDr. Herbst was selected for this award based on his distinguished and effective accomplishments in lung cancer research, having successfully integrated biology and laboratory research, team- based science, broad collaboration, and community, patient, public, and private partnerships that have served as a road map and role model for others. The work of Dr. Herbst and his team has importantly led to the approval of several treatments that have revolutionized lung cancer care, improved patient survival, and changed patient expectations. – Dr. Randall A. Oyer, MD, ACCC President end-quote

 

Nomination and Selection Process

Nominations and applications for the 2021 ACCC Annual Awards will open in March 2021. We encourage members to nominate their colleagues and peers in oncology. Questions? Please email Betsy Spruill, Member and Volunteer Engagement Manager, ACCC, or call 301.984.9496, ext. 206.
View Past Winners